Active Ingredient Mepolizumab

Active Ingredient Details

What is the usage for Mepolizumab?

This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. Mepolizumab is also used to treat a certain immune system diseases (eosinophilic granulomatosis with polyangiitis-EGPA, hypereosinophilic syndrome-HES). It helps to control and prevent symptoms (such as wheezing, shortness of breath, runny nose, facial pain, tiredness) caused by these diseases. It works by decreasing the amount of certain white blood cells (eosinophils) which may cause these diseases. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

How many products in the NDC database contain Mepolizumab?

The NDC database has 6 products with the active ingredient Mepolizumab. The following table lists all the products that have this active ingredient.

NDC Products with Mepolizumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0173-0881Proprietary Name: Nucala MepolizumabInjection, Powder, For SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0892Proprietary Name: Nucala MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
0173-0904Proprietary Name: Nucala MepolizumabInjection, SolutionSubcutaneousGlaxosmithkline LlcACTIVE
49401-012Proprietary Name: MepolizumabLiquidGlaxosmithkline LlcACTIVE
58437-004Proprietary Name: MepolizumabLiquidGlaxosmithkline LlcACTIVE
58437-009Proprietary Name: MepolizumabLiquidGlaxosmithkline LlcACTIVE
<